Result of General Meeting

Summary by AI ^BETAClose X

Fortis Frontier PLC announces that both resolutions presented at its general meeting were passed, approving the EIS Buyback Agreement and the GP Buyback Agreement. These agreements will facilitate the purchase and subsequent cancellation of 13,717,619 Ordinary Shares from Mercia. Following this cancellation, the Company's issued ordinary share capital will be 36,148,766 Ordinary Shares.

Disclaimer*

Fortis Frontier PLC

28 April 2026

Fortis Frontier PLC

("Fortis Frontier" or the "Company")

Result of General Meeting

Fortis Frontier PLC (AIM: FORF), an AIM Rule 15 cash shell (formerly MyHealthChecked PLC), announces that at general meeting held earlier today both resolutions were passed.

As such the EIS Buyback Agreement and the GP Buyback Agreement, to purchase, in aggregate, 13,717,619 Ordinary Shares from Mercia, as notified in the Company's announcement of 1 April 2026, are expected to complete shortly. The Buyback Shares will be cancelled.

Resolution	For	% For	Against	% Against	Withheld
1. To approve the terms of the EIS Buyback Agreement	8,581,297	98.47%	132,980	1.53%	9,728
2. To approve the terms of the GP Buyback Agreement	8,581,297	98.47%	132,980	1.53%	9,728

Total Voting Rights

Following cancellation, the Company's issued ordinary share capital will consist of 36,148,766 Ordinary Shares, with one vote per share. As the Company does not hold any Ordinary Shares in treasury this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

Unless otherwise defined, all definitions used in this announcement will have the same meaning as described in the Circular dated 1 April 2026.

For further information contact:

Fortis Frontier PLC	www.fortisfrontierplc-ir.com
Adam Reynolds, Executive Chairman	via Walbrook PR

SPARK Advisory Partners Limited (NOMAD)	Tel: +44 (0)20 3368 3550
Neil Baldwin / Dillon Wall

Singer Capital Markets (Broker)	Tel: +44 (0)20 7496 3000
James Serjeant / Russell Cook / Amber Higgs

Walbrook PR Ltd (Media & IR)	Tel: +44 (0)20 7933 8780 or fortisfrontier@walbrookpr.com
Paul McManus / Alice Woodings	Mob: +44 (0)7980 541 893 / +44(0)7407 804 654

About Fortis Frontier PLC

On 10 November 2025 MyHealthChecked PLC completed the disposal of its trading subsidiary, Concepta Diagnostics Limited, becoming an AIM Rule 15 Cash Shell, as defined in the AIM Rules for Companies. On the same day the Company changed its name to Fortis Frontier PLC. The Board is now carefully considering the strategic options available to it in order to maximise shareholder value.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END